Various factors such as TGF‐β1, PDGF, and anti‐PDGFR antibodies through fibroblast stimulation of SSc patients result in activating of Ras‐ERK1/2 signaling cascade that is followed by increased expression of reactive oxygen species (ROS). The gene discussed is MAPK3; the disease is systemic sclerosis.